NanoString Competitors and Similar CompaniesClear all

Personalis's competitors and similar companies include EKF Diagnostics, Viapath and 10X Genomics.
Personalis
Personalis
Personalis is a biotechnology company that specializes in cancer genomics.
EKF Diagnostics
EKF Diagnostics
EKF Diagnostics Holdings is a company that manufactures point-of-care (POCT) devices and tests for hemoglobin, glycated hemoglobin (HbA1c), glucose, and lactate.
Viapath
Viapath
Viapath provides pathology and testing its partners, and NHS and private sector organizations.
10X Genomics
10X Genomics
10X Genomics is a company building products for research institutions and pharmaceutical companies across the life sciences, including oncology, immunology, and neuroscience.
Founding Date
Founding Date
2011
Founding Date
1990
Founding Date
2009
Founding Date
2012
Type
Type
Public
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Fremont, US HQ
West Wickham, GB
Locations
Penarth, GB HQ
Shanghai, CN
Barleben, DE
Leipzig, DE
Boerne, US
Elkhart, US
Locations
Bedford, GB HQ
London, GB
London, GB
London, GB
London, GB
Orpington, GB
Locations
Pleasanton, US HQ
Shanghai, CN
Leiden, NL
Singapore, SG
San Francisco, US
Employees
Employees
22344% decrease
Employees
303
Employees
2701% decrease
Employees
1,17810% decrease
Valuation ($)
Valuation ($)
340.9 m
Valuation ($)
157.5 m
Valuation ($)
N/A
Valuation ($)
1.9 b

Financial

Revenue (est.)
Revenue (est.)
$69.6m (FY, 2025)
Revenue (est.)
£51.6m (FY, 2025)
Revenue (est.)
£122m (FY, 2018)
Revenue (est.)
$642.8m (FY, 2025)
Cost of goods
Cost of goods
$53.9m (FY, 2025)
Cost of goods
£19.7m (FY, 2025)
Cost of goods
£88.9m (FY, 2018)
Cost of goods
$198.9m (FY, 2025)
Gross profit
Gross profit
$15.8m (FY, 2025)
Gross profit
£32.1m (FY, 2025)
Gross profit
£33.1m (FY, 2018)
Gross profit
$443.9m (FY, 2025)
Net income
Net income
($81.3m) (FY, 2025)
Net income
£2.5m (FY, 2025)
Net income
£2.5m (FY, 2018)
Net income
($43.5m) (FY, 2025)

Operating

Patents Issued
Patents Issued
16 (FY, 2021)
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
200 (FY, 2019)

Funding

Total funding raised
Total funding raised
$ 75m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 195.5m
For sources of this data, please see the company profile

View Company Profiles

EKF Diagnostics
HQ
Penarth, GB
Employees
303

EKF Diagnostics Holdings is a company that manufactures point-of-care (POCT) devices and tests for hemoglobin, glycated hemoglobin (HbA1c), glucose, and lactate.

View company
Viapath
HQ
Bedford, GB
Employees
270↓ 1% decrease

Viapath provides pathology and testing its partners, and NHS and private sector organizations.

View company
10X Genomics
HQ
Pleasanton, US
Employees
1,178↓ 10% decrease

10X Genomics is a company building products for research institutions and pharmaceutical companies across the life sciences, including oncology, immunology, and neuroscience.

View company